| Medications | ||||||||
|---|---|---|---|---|---|---|---|---|
| Antihypertensives, % | ||||||||
| ACEi | 14 | 16 | 20 | 0.80 | ||||
| ARB | 86 | 84 | 80 | 0.80 | ||||
| Diuretic | 46 | 60 | 67 | 0.2 | ||||
| Calcium channel blocker | 64 | 60 | 75 | 0.51 | ||||
| Beta blocking agent | 26 | 32 | 30 | 0.86 | ||||
| Alpha blocking agent | 18 | 32 | 17 | 0.31 | ||||
| Other treatments, % | ||||||||
| Anticoagulant agent | 40 | 48 | 25 | 0.24 | ||||
| Lipid lowering agents | 74 | 76 | 84 | 0.67 | ||||
| Antidiabetic agent | 28 | 46 | 28 | 0.36 | ||||
Values are expressed as mean ± SD or percentages (%). P-value was calculated using one-way ANOVA. BMI: body mass index; HDL: high-density lipoprotein cholesterol; LDL: low-density lipoprotein cholesterol; eGFR: estimated glomerular filtration rate. N: normoalbuminuria; dnA: de novo albuminuria; SA: sustained albuminuria.